Benzinga | Jul 27, 2020 04:09PM EDT

Champions Oncology Q4 Sales $8.80M Beat $8.29M Estimate

Champions Oncology (NASDAQ:CSBR) reported quarterly sales of $8.80 million which beat the analyst consensus estimate of $8.29 million by 6.15 percent. This is a 14.02 percent increase over sales of $7.72 million the same period last year.